Insulin Biosimilars: Advancing Treatment Options for Diabetes Patients What Are They?As biologic drugs like insulin approach the end of their patent life, biosimilar versions are being developed and approved to help increase competition and access to treatment. But what exactly are insulin biosimilars? A biosimilar is a biologic medical product that is highly similar to an already approved biologic reference product, known as the original innovator biologic....
0 Distribuiri
242 Views
0 previzualizare